Cormorant Asset Management, LP Diversified Active

Location: Boston, MA

CIK: 0001583977 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 14, 2018

Total Value: $1.539B (100.0% shares, 0.0% debt)

Holdings (65)

ANAB ANAPTYSBIO INC 7.4%
Value $113M Shares 1,135,000 Est. Cost $39.24 Unrealized +111.4%
MIRATI THERAPEUTICS INC 5.5%
Value $85.25M Shares 1,810,000 Est. Cost $19.29 Unrealized
NEKTAR THERAPEUTICS 5.4%
Value $83.52M Shares 1,370,000 Est. Cost $69.99 Unrealized
NEKTAR THERAPEUTICS 5.3%
Value $80.98M Shares 1,328,400 Est. Cost $69.99 Unrealized
AVROBIO INC 5.0%
Value $77.43M Shares 1,492,784 Est. Cost $28.56 Unrealized
APLS APELLIS PHARMACEUTICALS INC 4.8%
Value $74.19M Shares 4,172,498 Est. Cost $15.52 Unrealized +19.1%
DICERNA PHARMACEUTICALS INC 3.5%
Value $54.27M Shares 3,556,669 Est. Cost $9.03 Unrealized
REATA PHARMACEUTICALS INC 3.5%
Value $53.96M Shares 660,000 Est. Cost $43.21 Unrealized
TESARO INC 3.2%
Value $48.76M Shares 1,250,000 Est. Cost $44.96 Unrealized
IFRX INFLARX NV 3.0%
Value $46.04M Shares 1,341,540 Est. Cost $18.95 Unrealized +70.2%
MYOKARDIA INC 3.0%
Value $45.64M Shares 700,000 Est. Cost $17.38 Unrealized
PRINCIPIA BIOPHARMA INC 2.8%
Value $43.45M Shares 1,486,898 Est. Cost $29.22 Unrealized
AUTL AUTOLUS THERAPEUTICS PLC 2.6%
Value $40.67M Shares 1,326,136 Est. Cost $26.79 Unrealized
RCKT ROCKET PHARMACEUTICALS INC 2.4%
Value $36.95M Shares 1,500,659 Est. Cost $16.31 Unrealized +33.0%
QUOTIENT LTD 2.4%
Value $36.62M Shares 4,850,000 Est. Cost $8.95 Unrealized
TBPH THERAVANCE BIOPHARMA INC 2.3%
Value $35.94M Shares 1,100,000 Est. Cost $24.80 Unrealized +9.9%
G1 THERAPEUTICS INC 2.2%
Value $33.49M Shares 640,481 Est. Cost $20.91 Unrealized
KEZAR LIFE SCIENCES INC 2.2%
Value $33.25M Shares 1,552,911 Est. Cost $17.30 Unrealized
SOLID BIOSCIENCES INC 2.1%
Value $31.64M Shares 670,513 Est. Cost $7.49 Unrealized
BLUEPRINT MEDICINES CORP 1.9%
Value $29.66M Shares 380,000 Est. Cost $66.58 Unrealized
OMER OMEROS CORP 1.8%
Value $27.75M Shares 1,136,900 Est. Cost $16.18 Unrealized +37.8%
SAGE THERAPEUTICS INC 1.7%
Value $26.84M Shares 190,000 Est. Cost $161.07 Unrealized
ASND ASCENDIS PHARMA A S 1.6%
Value $24.8M Shares 350,000 Est. Cost $44.95 Unrealized
ZOGENIX INC 1.6%
Value $24.8M Shares 500,000 Est. Cost $49.60 Unrealized
OMER OMEROS CORP 1.6%
Value $24.41M Shares 1,000,000 Est. Cost $16.18 Unrealized +37.8%
TRICIDA INC 1.5%
Value $22.44M Shares 734,588 Est. Cost $29.90 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 1.4%
Value $21.52M Shares 175,000 Est. Cost $15.30 Unrealized +641.8%
KINIKSA PHARMACEUTICALS LTD 1.4%
Value $21.19M Shares 831,000 Est. Cost $16.66 Unrealized
TESARO INC 1.3%
Value $19.5M Shares 500,000 Est. Cost $44.96 Unrealized
ARENA PHARMACEUTICALS INC 1.2%
Value $18.87M Shares 410,000 Est. Cost $42.46 Unrealized
INCY INCYTE CORP 1.2%
Value $17.96M Shares 260,000 Est. Cost $68.44 Unrealized +0.3%
ZLAB ZAI LAB LTD 1.0%
Value $15.74M Shares 808,166 Est. Cost $22.58 Unrealized
ARGX ARGEN SE 0.9%
Value $14.41M Shares 190,000 Est. Cost $63.14 Unrealized
INSP INSPIRE MED SYS INC 0.8%
Value $12.62M Shares 300,000 Est. Cost $32.28 Unrealized +45.4%
ZOGENIX INC 0.8%
Value $12.4M Shares 250,000 Est. Cost $49.60 Unrealized
BIOHAVEN PHARMACTL HLDG CO L 0.6%
Value $9.763M Shares 260,000 Est. Cost $26.98 Unrealized
ARRAY BIOPHARMA INC 0.6%
Value $9.12M Shares 600,000 Est. Cost $6.75 Unrealized
RUBIUS THERAPEUTICS INC 0.6%
Value $8.749M Shares 364,559 Est. Cost $24.00 Unrealized
CONSTELLATION PHARMCETICLS I 0.6%
Value $8.558M Shares 1,271,687 Est. Cost $6.73 Unrealized
SPECTRUM PHARMACEUTICALS INC 0.5%
Value $8.4M Shares 500,000 Est. Cost $20.96 Unrealized
AMARIN CORP PLC 0.5%
Value $8.135M Shares 500,000 Est. Cost $16.27 Unrealized
MINERVA NEUROSCIENCES INC 0.5%
Value $7.629M Shares 607,903 Est. Cost $7.26 Unrealized
REPL REPLIMUNE GROUP INC 0.5%
Value $7.531M Shares 467,792 Est. Cost $17.53 Unrealized 0.0%
ACRS ACLARIS THERAPEUTICS INC 0.5%
Value $7.26M Shares 500,000 Est. Cost $19.94 Unrealized -14.0%
ABEONA THERAPEUTICS INC 0.4%
Value $6.4M Shares 500,000 Est. Cost $8.20 Unrealized
CONTRAFECT CORP 0.4%
Value $6.21M Shares 3,000,000 Est. Cost $2.80 Unrealized
SRRK SCHOLAR ROCK HLDG CORP 0.4%
Value $5.41M Shares 210,078 Est. Cost $18.88 Unrealized -2.7%
HRTX HERON THERAPEUTICS INC 0.3%
Value $5.381M Shares 170,000 Est. Cost $15.72 Unrealized +136.9%
Y MABS THERAPEUTICS INC 0.3%
Value $5.312M Shares 200,000 Est. Cost $26.56 Unrealized
AUDENTES THERAPEUTICS INC 0.3%
Value $4.949M Shares 125,000 Est. Cost $18.38 Unrealized
TRANSLATE BIO, INC 0.3%
Value $4.546M Shares 454,550 Est. Cost $12.65 Unrealized
EIDOS THERAPEUTICS INC 0.3%
Value $3.851M Shares 385,846 Est. Cost $19.32 Unrealized
COLL COLLEGIUM PHARMACEUTICAL INC 0.2%
Value $3.685M Shares 250,000 Est. Cost $17.28 Unrealized +2.6%
AKCEA THERAPEUTICS INC 0.2%
Value $3.502M Shares 100,000 Est. Cost Unrealized
SGMO SANGAMO BIOSCIENCES INC 0.2%
Value $3.39M Shares 200,000 Est. Cost $6.37 Unrealized +138.5%
MGTX MEIRAGTX HOLDINGS PLC 0.2%
Value $3.245M Shares 238,579 Est. Cost $13.41 Unrealized -19.4%
ITERUM THERAPEUTICS PLC 0.2%
Value $3.196M Shares 476,968 Est. Cost $10.89 Unrealized
MARINUS PHARMACEUTICALS INC 0.2%
Value $3M Shares 300,000 Est. Cost $8.16 Unrealized
TRILLIUM THERAPEUTICS INC 0.2%
Value $2.9M Shares 500,000 Est. Cost $4.40 Unrealized
ACCELERON PHARMA INC 0.2%
Value $2.862M Shares 50,000 Est. Cost $32.04 Unrealized
CLEARSIDE BIOMEDICAL INC 0.2%
Value $2.46M Shares 400,000 Est. Cost $7.30 Unrealized
ARQULE INC 0.1%
Value $1.698M Shares 300,000 Est. Cost $5.66 Unrealized
QTRX QUANTERIX CORP 0.1%
Value $1.177M Shares 54,945 Est. Cost $19.52 Unrealized -19.0%
ONCOBIOLOGICS INC - CW17 -A 0.0%
Value $9,000 Shares 416,666 Est. Cost $0.46 Unrealized
CELLECTAR BIOSCIENCES-CW19 0.0%
Value $4,000 Shares 52,999 Est. Cost $0.55 Unrealized